Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
The patent application describes an optimized expression system to produce a world-first fully synthetic recombinant version of PRP
-
Preclinical in vivo efficacy data (PoC) in atopic dermatitis of disease-modifying therapy; positive patent opinion from the EU Patent Office
-
Biopharmaceutical company, Renexxion Ireland, is granted its sixth U.S. patent for naronapride as it continues to advance new therapies for GI disorders.
-
MINNEAPOLIS, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company advancing precision fluid management technologies across the cardio-renal continuum today...
-
Fort Lauderdale, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Blank Rome LLP is pleased to announce that Mark D. Passler and Ryan L. Harding have joined the firm as partners in the Intellectual Property &...
-
Nutriband New Year Letter to Shareholders
-
Nutriband signs agreement to sell majority stake in Pocono for $5M
-
Quanta LOI
-
Fentanyl designation Response
-
Longeveron granted US patent for method of treating female sexual dysfunction using its proprietary stem cell therapy laromestrocel.